Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-14

Clinical Trial Update: Once Daily Gabapentin in the Treatment of Post Amputation Pain [Phase 3]

View source ↗

Summary

Phase 3 trial update on once-daily gabapentin for post-amputation pain; status and detailed results are not provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

Sponsor: Chicago Anesthesia Pain Specialists | Conditions: Pain, Quality of Life | Phase 3 | Status: UNKNOWN